Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Creo Medical Group Fundamentals

Company Name Creo Medical Group Last Updated 02 Jul 2020
Industry Health Care Sector Medical Equipment
Shares in Issue (m) 157.52 Market Cap (£m) 329.22
PE Ratio -16.08 Div per Share () 0.00
Div Yield 0.00 Div Cover 0.00
EPS -13.00 EPS Growth (%) 18.75
PEG -0.86 DPS Growth (%) n/a
Debt Ratio 0.65 Debt Equity Ratio 0.10
Net Gearing -85.48 Gross Gearing 6.35
Asset Equity Ratio 1.07 Cash Equity Ratio 98.05
Quick Ratio 16.88 Current Ratio 17.03
Price To Book Value 3.98 ROCE -22.38

Creo Medical Group Dividends

Type Ex-Date Pay Date Currency Net Dividend Year Total

Creo Medical Group Company Financials

Assets (£m) 2019 2018 2017
Tangible Assets 1 1 0
Intangible Assets 1 0 0
Investments 0 0 0
Total Fixed Assets 2 1 0
Stocks 1 0 0
Debtors 2 1 1
Cash & Equivalents 81 45 14
Other Assets 3 3 1
Total Assets 88 50 16
Liabilities (£m) 2019 2018 2017
Creditors within 1 year 5 2 1
Creditors after 1 year 1 0 0
Other Liabilities 0 0 0
Total Liabilities 6 2 1
Net assets 83 48 15
Equity (£m) 2019 2018 2017
Called up share capital 0 0 0
Share Premium 115 66 20
Profit / Loss -19 -18 -9
Other Equity 18 17 15
Preference & Minorities 0 0 0
Total Capital Employed 83 48 15
Ratios 2019 2018 2017
Debt Ratio 0.65 0.82 0.01
Debt-to-Equity 0.10 0.19 0.00
Net Gearing -85.48 -85.55 -75.78
Gross Gearing 6.35 4.09 9.12
Assets / Equity 1.07 1.04 1.10
Cash / Equity 98.05 93.45 93.42
EPS -13.00 -16.00 -13.00
Cash Flow (£m) 2019 2018 2017
Cash from operating activities -12 -14 -7
Cashflow before financing -13 -16 -7
Increase in Cash 36 31 13
Income (£m) 2019 2018 2017
Turnover 0 0 0
Cost of sales 0 0 0
Gross Profit 0 0 0
Operating Profit -19 -18 -9
Pre-Tax profit -19 -18 -9
Profit / Loss for the year 0 0 0

Creo Medical Group Company Background

Sector Medical Equipment
Activities Creo Medical Group plc, founded in 2003, is a medical device company focused on the development and commercialisation of minimally invasive surgical devices, by bringing advanced energy to endoscopy. The Company's mission is to improve patient outcomes by applying microwave and RF energy to surgical endoscopy. Creo has developed CROMA, an electrosurgical advanced energy platform that combines bipolar radiofrequency for precise localised cutting and microwave for controlled coagulation. This technology provides clinicians with flexible, accurate and controlled surgical solutions. The Company's strategy is to bring its CROMA platform to market through a suite of medical devices which the Company has designed, initially for the emerging field of GI therapeutic endoscopy, an area with high unmet needs. The CROMA platform will be developed further for bronchoscopy and laparoscopy procedures. The Company believes its technology can impact the landscape of surgery and endoscopy by providing a safer, less-invasive and more cost-efficient option of treatment.
Latest Interim Date 30 Sep 2019
Latest Fiscal Year End Date 07 May 2020

Creo Medical Group Directors

Appointed Director Position
2016-09-12 Craig Jonathan Gulliford Chief Financial Officer
2016-09-12 Richard John Rees Chief Financial Officer
2016-09-12 Dr Christopher Paul Hancock Chief Technology Officer
2016-12-05 Charles Alexander Evan Spicer Non-Executive Chairman
2016-12-05 John Bradshaw Non-Executive Director
2016-12-05 David Gerard Woods Non-Executive Director
2020-02-01 Ivonne Maria Gloria Cantu Non-Executive Director

Creo Medical Group Contact Details

Company Name Creo Medical Group
Company Address Riverside Court, Beaufort Park Way, Chepstow NP16 5UH.
Company Telephone +44 (0)1291 606005
Company Website http://www.creomedical.com/

Creo Medical Group Advisors

Auditor Name KPMG Audit
Auditor Address 100 Temple Street, Bristol BS1 6AG.
Auditor Website http://www.kpmg.com/
Auditor Telephone +44 (0)1179 054 000
Registrar Name Equiniti
Registrar Address Aspect House, Spencer Road, Lancing, West Sussex BN99 6DA.
Registrar Website http://www.equiniti.com/
Registrar Telephone 0871 384 2030
Broker Name Cenkos Securities Limited
Broker Address 6.7.8. Tokenhouse Yard, London EC2R 7AS.
Broker Website http://www.cenkos.com/
Broker Telephone +44 (0)20 7397 8900
Adviser Name Cenkos Securities Limited
Adviser Address 6.7.8. Tokenhouse Yard, London EC2R 7AS.
Adviser Website http://www.cenkos.com/
Adviser Telephone +44 (0)20 7397 8900
Solicitor Name Taylor Wessing
Solicitor Address 5 New Street Square, London EC4A 3TW.
Solicitor Website http://www.taylorwessing.com/
Solicitor Telephone +44 (0)20 7300 7000
Stockbroker Name n/a
Stockbroker Address n/a
Stockbroker Website n/a
Stockbroker Telephone n/a